500mg Riturirel Rituximab Injection

500mg Riturirel Rituximab Injection Specification

Brand Name
Riturirel

Origin of Medicine
India

Salt Composition
Rituximab 500mg

Pacakaging (Quantity Per Box)
1 vial per box

Life Span
24 months from manufacture date

Dosage Form
Injectable lyophilized powder

Indication
Indicated for CD20-positive B-cell non-Hodgkins lymphoma and other autoimmune diseases as prescribed

Packaging Type
Vial with carton box

Drug Type
Prescription Biological

Ingredients
Rituximab (500mg) as active ingredient

Physical Form
Lyophilized powder for reconstitution

Function

Recommended For
Non-Hodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis, Microscopic polyangiitis

Dosage
As directed by a healthcare professional, typically based on body surface area or clinical indication

Dosage Guidelines
Administer only as intravenous infusion after dilution; premedicate with antihistamines and antipyretics as per guidelines

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Administration Route
Intravenous infusion only

Color
White to off-white powder

Reconstitution Solvent
Sterile water for injection

Molecular Weight
Approximately 145 kDa

Compatibility
Dilute only with recommended IV solutions as per product insert

Therapeutic Class
Immunosuppressant, Monoclonal Antibody

Handling Precautions
Prepare and administer under aseptic conditions by trained healthcare professional

Molecular Formula
C6416H9874N1688O1987S44

Approval
Approved by DCGI (India) and conforms to international pharmacopoeia standards

Disposal
Unused product or waste material should be disposed of in accordance with local requirements

Contraindications
Hypersensitivity to Rituximab, active severe infections

Side Effects
Infusion related reactions, fever, chills, infections, hypotension, neutropenia

ATC Code
L01XC02

500mg Riturirel Rituximab Injection Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 500mg Riturirel Rituximab Injection

Strength	500mg
Packaging Type	Box
Packaging Size	50ml
Brand	Riturirel
Manufacturer	Reliance
Composition	Rituximab
Treatment	Cancer

Reditux 500 mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Reditux 500 mg Injection is give under the supervision of doctor. You must take it in a dose as advised by the doctor. The duration of treatment varies on the basis of your need and response to treatment. However, before taking it inform your doctor if you have any heart rhythm problems, if you are having surgery or if you plan to get any vaccinations. Your doctor may get blood tests done to check for hepatitis B before treatment and to check your blood cells during treatment with this medicine. You should inform doctor immediately if you notice any signs of infection such as fever, sore throat or rash.

Precisely Targeted Therapy

Riturirel delivers targeted cancer and immunotherapy via monoclonal antibody action against CD20-positive B cells. This approach enhances efficacy while minimizing unwanted effects on healthy cells, making it suitable for adult patients with non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and specific autoimmune diseases. Rituximab's targeted mechanism provides improved disease control for suitable indications.

Safe and Professional Administration

Riturirel must be prepared and administered by trained healthcare professionals under aseptic conditions. The lyophilized powder is reconstituted with sterile water and further diluted according to the product insert. Intravenous infusion is the sole route of administration, with dosage guided by indication and patient body surface area to ensure safe, effective treatment.

Strict Handling and Storage Requirements

Store Riturirel at 2C to 8C and protect it from light. Never freeze the vial. Proper handling, including correct disposal of unused medicine and waste, is essential and should follow local regulations. These precautions maintain product integrity and reduce the risk of accidental exposure or contamination.

FAQ's of 500mg Riturirel Rituximab Injection:

Q: How should Riturirel Rituximab Injection be prepared and administered?

A: Riturirel must be reconstituted with the provided sterile water for injection and diluted with the recommended IV solution as outlined in the product insert. It is administered exclusively by intravenous infusion under aseptic conditions by trained healthcare professionals.

Q: What are the primary uses and benefits of Riturirel Rituximab Injection?

A: Riturirel is indicated for adult patients with CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, certain autoimmune diseases like rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Its benefit lies in targeted therapy, which selectively attacks abnormal B cells while sparing healthy tissues.

Q: When is it not appropriate to use Riturirel Rituximab Injection?

A: This medication is contraindicated in individuals with known hypersensitivity to Rituximab or any component of the formulation, and in those with active severe infections. Always consult a healthcare provider to determine suitability.

Q: Where should Riturirel be stored, and what are key precautions?

A: Store Riturirel at 2C to 8C, away from light, and do not freeze. The product should be kept in its original packaging until use and handled according to local safety and disposal protocols to ensure safety and stability.

Q: What possible side effects should patients be aware of during treatment?

A: Common side effects include infusion-related reactions such as fever, chills, hypotension, infections, and neutropenia. Premedication with antihistamines and antipyretics is generally recommended to minimize infusion reactions.

Q: What is the process for using Riturirel and who can administer it?

A: Only a trained healthcare professional should prepare and administer Riturirel. The process involves reconstituting the lyophilized powder with sterile water, diluting it, and infusing it intravenously according to prescribed dosage and clinical guidelines.

Q: Why is premedication advised before administering Riturirel?

A: Premedicating with antihistamines and antipyretics helps reduce the risk and severity of infusion-related reactions, which can occur with administration of Rituximab.